Dose Escalation and Expansion Study of HM97662 in Advanced or Metastatic Solid Tumors

NCT05598151 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

170

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG: HM97662

Sponsor

Hanmi Pharmaceutical Company Limited